Wordt geladen...
Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome
BACKGROUND: Atypical hemolytic uremic syndrome (aHUS) is a rare genetic disorder caused by chronic uncontrolled complement activation. CASE-DIAGNOSIS/TREATMENT: We present a 4-year-old girl with aHUS who had multiple severe clinical manifestations of thrombotic microangiopathy (TMA) including acute...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer-Verlag
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3491201/ https://ncbi.nlm.nih.gov/pubmed/22890512 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-012-2276-8 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|